XLerateHealth focuses on early-stage healthcare startups, particularly in the Midwest and Southeast regions of the United States. They primarily engage in pre-seed and seed investment rounds, offering a nationally recognized 12-week accelerator program to help startups increase their chances of success. The firm's goal is to support impactful healthcare innovation that might otherwise go unrecognized and underfunded.
Notable portfolio companies include Amplified Sciences, Apellis Pharmaceuticals, and RxLightning. XLerateHealth connects startups with clinical, academic, and business leaders to provide comprehensive guidance. Key partners and mentors bring a wealth of expertise from various sectors, enhancing the firm's ability to offer unique value-add services such as strategic advice and industry connections.
XLerateHealth - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies29
Current Portfolio Count27
Total Portfolio Exits1
Top Investment Stages
Pre-Seed19 (70.4%)
Seed8 (29.6%)
Stage Mix
Pre-Seed 70%Seed 30%
Concentration shown as share of disclosed investments by stage.